Hinge Bio logo

Hinge Bio Funding & Investors

Burlingame, CA

Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies. It features chemical ligation process technology that enables the production of therapeutic candidates with orders-of-magnitude improved affinity and specificity. The company was founded in 2015 and headquartered in Burlingame, California.

hingebio.com

Total Amount Raised: $30,224,456

Hinge Bio Funding Rounds

  • Series A

    $30,000,000

    Series A Investors

    Point72
    InVivium Capital
    Lightswitch Capital
  • Grant

    $224,455

    Grant Investors

    National Science Foundation (NSF)
Funding info provided by Diffbot.